Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa

AIDS Research and Human Retroviruses

Volumn 17, Issue 10, 2001, Pages 901-910

  Fideli, ÜLGEN Semaye ^a   Allen, Susan A ^a   Musonda, Rosemary ^b   Trask, Stan ^c   Hahn, Beatrice H ^c   Weiss, Heidi ^c   Mulenga, Joseph ^d   Kasolo, Francis ^e   Vermund, Sten H ^a,f,g   Aldrovand, G M ^h  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b TROPICAL DISEASES RESEARCH CENTRE   (Zambia)

^c UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^d Zambia National Blood Transfusion Service   (Zambia)

^e UNIVERSITY TEACHING HOSPITAL   (Zambia)

^f University of Alabama at Birmingham   (United States)

^g University of Alabama at Birmingham   (United States)

^h University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ADULT; ARTICLE; CELL LEVEL; CONTROLLED STUDY; DISEASE TRANSMISSION; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SEROCONVERSION; SEXUAL TRANSMISSION; T LYMPHOCYTE; VIRUS ISOLATION; VIRUS LOAD; ZAMBIA;

ADOLESCENT; ADULT; AFRICA; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; HETEROSEXUALITY; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; PHYLOGENY; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; RNA, VIRAL; SEQUENCE ANALYSIS, RNA; VIRAL LOAD;

EID: 0034826484     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922201750290023     Document Type: Article

References (60)

1. Confidential HIV testing and condom promotion in Africa. Impact on HIV and gonorrhea rates
2. Genetic subtypes of HIV-1
3. Factors influencing human immunodeficiency virus type 1 transmission by blood transfusion
4. A case-control study of HIV seroconversion in health care workers after percutaneous exposure
5. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load
6. Vertical HIV-1 transmission correlates with a high maternal viral load at delivery
7. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine
8. Maternal viral load and vertical transmission of HIV-1 An important factor but not the only one. The European Collaborative Study
9. Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery
10. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: A randomised controlled trial
11. Heterosexual transmission of human immunodeficiency virus: Variability of infectivity throughout the course of infection
12. Sex differences in HIV-1 viral load and progression to AIDS
13. Sex differences in longitudinal human immunodeficiency virus type 1 RNA levels among seroconverters
14. Gender differences in HIV-1 diversity at time of infection
15. HIV-1 subtypes and male-to-female transmission in Thailand
16. Heterosexual transmission of human immunodeficiency virus Association with severe depletion of T-helper lymphocytes in men with hemophilia
17. Biological correlates of HIV-1 heterosexual transmission
18. Heterosexual transmission of HIV-1 is associated with high plasma viral load levels and a positive viral isolation in the infected partner
19. Man-to-woman sexual transmission of the human immunodeficiency virus. Risk factors related to sexual behavior, man's infectiousness, and woman's susceptibility
20. Sexual transmission of HIV
21. Viral load heterosexual transmission of human immunodeficiency virus type 1
22. Rapid HIV testing and counseling for voluntary testing centers in Africa
23. The evolution of voluntary testing and counseling as an HIV prevention strategy
24. The neighbor-joining method: A new method for reconstructing pylogenetic trees
25. A simple method for estimating evolutionary rates of base substitutions through competitive studies of nucleotide sequences
26. Classification of HIV infection and disease in women from Rwanda. Evaluation of the World Health Organization HIV staging system and recommended modifications
27. Comparative analysis of commercial PCR assays for the quantitation of plasma, HIV-1 RNA in patients infected with HIV-1 subtype C
28. Assay of plasma samples representing different HIV-1 genetic subtypes: An evaluation of new versions of the Amplicor HIV-1 Monitor assay
29. Comparison of CD4 cell count by a simple enzyme-linked immunosorbent assay using the TRAx CD4 test kit and by flow cytometry and hematology
30. Helper T-lymphocyte count. TRAx CD4 test kit versus conventional flow cytometry
31. Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates
32. A SAS program for the computation of seroconversion rates in a prospective study of HIV discordant couples in Lusaka, Zambia
33. Sample size requirements and length of study for testing interaction in a 2 × k factorial design when time-to-failure is the outcome
34. The social dynamics of HIV transmission as reflected through discordant couples in rural Uganda
35. Effect of serotesting with counselling on condom use and seroconversion among HIV discordant couples in Africa
36. Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya
37. Human immunodeficiency virus type 1 subtypes differ in disease progression
38. Efficiencies of four versions of the AMPLICOR HIV-1 MONITOR test for the quantification of different subtypes of human immunodeficiency virus
39. Heterosexual transmission of human immunodeficiency virus (HIV) in northern California: Results from a ten-year study
40. Man-to-woman sexual transmission of HIV: Longitudinal study of 343 steady partners of infected men
41. Heterosexual transmission of HIV in Haiti
42. A longitudinal study of human immunodeficiency virus transmission by heterosexual partners
43. Human immunodeficiency virus type 1 RNA shedding in the female genital tract
44. Distinct determinants of human immunodeficiency virus type 1 RNA and DNA loads in vaginal and cervical secretions
45. Correlation of human immunodeficiency virus type RNA levels in blood and the female genital tract
46. Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: Evidence for compartmentalization of HIV-1 between semen and blood
47. Effect of antiviral treatment on the shedding of HIV-1 in semen
48. Quantitation of human immunodeficiency virus type 1 RNA in cell free seminal plasma: Comparison of NASBA with Amplicor reverse transcription-PCR amplification and correlation with quantitative culture
49. Analysis of HIV-1 load in blood, semen and saliva: Evidence for different viral compartments in a cross-sectional and longitudinal study
50. Heterosexual HIV-1 transmission and viral load in hemophilic patients
51. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant
52. Risk factors for woman-to-man sexual transmission of the human immunodeficiency virus
53. High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors
54. Persistence of human immunodeficiency virus in semen after adding indinavir to combination antiretroviral therapy
55. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy
56. Immune control of HIV-1 after early treatment of acute infection
57. Rationale for the testing and use of a partially effective HIV vaccine